ASX:1AIPharmaceuticals, Biotechnology & Life SciencesBiotechnology
ALGORAE PHARMACEUTICALS ORD
$0.014
+$0.001 (+7.69%)
Day Range
$0.013 - $0.014
52 Week Range
$0.005 - $0.024
Volume
616.82K
Avg Volume (10D)
779.14K
Market Cap
$28.32M
Price Chart
Market Statistics
Open$0.013
Previous Close$0.013
Day High$0.014
Day Low$0.013
52 Week High$0.024
52 Week Low$0.005
Valuation
Market Cap28.32M
Shares Outstanding2.02B
Price to Book11.62
Trading Activity
Volume616.82K
Value Traded8.49K
Bid$0.013 × 247,960
Ask$0.014 × 1,615,976
Performance
1 Day0.00%
5 Day-7.14%
13 Week-43.48%
52 Week85.71%
YTD-7.14%
Technical Indicators
RSI (14)52.83
50-Day SMA$0.014
200-Day SMA$0.013
Latest News
Biotechnology
Algorae Pharmaceuticals Enters Second Drug Synergy Screening Program with Peter MacCallum Cancer Centre
Algorae launches second AOS2 synergy program with Peter MacCallum Cancer Centre's VCFG; 24 drug combos across cancers; six-month preclinical data.
1 min read
Biotechnology
Algorae Pharmaceuticals Partners with Cadila to Market Two New Medicines in Australia and NZ
Algorae inks Cadila deal to market two cardio/metabolic generics in Australia & NZ; Cadila develops/manufactures; AlgoraeRx handles regulatory and marketing.
1 min read
Biotechnology
Algorae Pharmaceuticals Advances Commercial Pathway as AI Platform Validation and Distribution Agreements Gather Pace
Algorae Pharmaceuticals (ASX: 1AI) advances AlgoraeOS validation and signs Dr Reddy's distribution, signals near-term oncology revenue and stronger balance sheet.
2 min read
Biotechnology
Algorae Pharmaceuticals Identifies 90 New Drug-Combination Candidates from AlgoraeOS V2 Analysis
Algorae Pharmaceuticals (ASX: 1AI) has identified 90 high-quality drug-combination candidates following a preliminary review of newly delivered in silico synergy predictions generated by its upgraded AlgoraeOS v2 platform.
1 min read